Skip to main content Skip to section navigation Skip to footer
CohBar, Inc.
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Programs & Pipelines
    • Overview
    • Our Approach
    • CB5138-3
    • CB4211
    • CB5064 Analogs
    • Posters & White Papers
  • Patient Resources
    • Overview
  • News & Media
    • Press Releases
    • Presentations
    • Events
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Partners
  • Careers
  • Contact

Press Releases

News & Media

News & Media

  • Press Releases
  • Presentations
  • Events
Feb 01, 2017 8:00am EST

CohBar Inc. to Webcast, Live, at VirtualInvestorConferences.com February 2

Jan 11, 2017 9:44am EST

CohBar, Inc. Announces Expiration of Warrants and Reports Aggregate Proceeds from Warrant Exercises

Jan 10, 2017 8:06pm EST

CohBar, Inc.’s CEO Simon Allen to Present at the 9th Annual Biotech Showcase in San Francisco

Dec 06, 2016 9:00am EST

CohBar, Inc. Continues Exploration of Mitochondrial Genome and Expansion of Its IP Portfolio with Filing of 29 New Provisional Patents

Nov 14, 2016 9:00am EST

CohBar, Inc. Announces Third Quarter 2016 Financial Results

Oct 18, 2016 9:00am EDT

CohBar, Inc.’s CEO Simon Allen to Present at BIO Investor Forum 2016

Oct 13, 2016 9:00am EDT

CohBar, Inc. Announces Discovery of New Peptides in the Mitochondrial Genome

Sep 30, 2016 9:00am EDT

CohBar Advances First-in-Class Mitochondria Based Therapeutic to IND-Enabling Activities

Aug 15, 2016 9:00am EDT

CohBar, Inc. Announces Second Quarter 2016 Financial Results

May 31, 2016 9:00am EDT

CohBar, Inc. to Hold 2016 Annual Shareholder Meeting and Investor Update June 14, 2016

  • arrow_back
  • 1…
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • arrow_forward
©2022 CohBar, Inc. All Rights Reserved.
Privacy Policy Sitemap Terms of Use